MCK vs CAH — Key Metrics

Metric MCK (MCKESSON CORP) CAH (CARDINAL HEALTH INC)
Price1084.43278.32
Market Cap125.2 Billion64.33 Billion
P/E (TTM)27.8135.82
P/B (Quarterly)-31.228-20.464
P/S (TTM)0.30.25
Net Profit Margin (TTM)1.10.7
Gross Margin (TTM)3.73.9
ROE (TTM)-161.2-62.6
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

MCKESSON CORP
vs
 
CARDINAL HEALTH INC
 
MCKESSON CORP
vs
 
CARDINAL HEALTH INC
Performance Comparison
AI Model Recommendation
MCK · MCKESSON CORP

Greatly Outperform

83
UnderperformOutperform
CAH · CARDINAL HEALTH INC

Greatly Outperform

64
UnderperformOutperform
Recommendation Summary

Both stocks are projected to significantly outperform the market over the next year. If you have to make a choice, Upfront Recommendation: MCK.

Financial Metrics
Prices delayed ~15 min
MCK Metrics CAH
$1,084.43 Price $278.32
— Market Capitalization —
27.81 Price to Earnings Ratio 35.82
0.3 Price to Sales 0.25
18.23 Price to FCF Ratio 13.0
8.15 Price to Gross Profit 6.4
1.88 Price to Current Assets 1.57

MCK vs CAH at a glance

Mckesson Corp (MCK) and Cardinal Health INC (CAH) are both Medical Distribution companies in the Healthcare sector. MCK is the larger, at $125.2 billion in market value against $64.3 billion for CAH, about 1.9 times the size.

On trailing-twelve-month figures, MCK trades at 27.8 times trailing earnings and CAH at 35.8; net profit margins are 1.1% and 0.7%.

The Upfront Investment model currently rates both Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.